Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT07066826 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Dementia

Interventions

DRUG: Huperzine A Controlled-Release Tablets
DRUG: Donepezil hydrochloride tablets
DRUG: Huperzine A controlled-release tablets placebo; Donepezil hydrochloride tablets placebo

Sponsor

Wanbangde Pharmaceutical Group Co., LTD